The primary goal of the recently renamed Functional Genomics and Microbiome Core (Core C) is to enhance research programs in infection and injury states affecting the mammalian intestine and liver by providing genomics and metagenomics expertise and resources. In this Core, we utilize advanced technology in mammalian and microbial genomics to support ongoing and innovative research to prevent and cure digestive diseases. This Core enables investigators to posit research questions related to gene expression, functional genomics and molecular mechanisms by utilizing the tools of microarrays, deep nucleic acid sequencing (microbial and mammalian), nucleic acid amplification, protein profiling, and bioinformatics. PCR based analyses of gene expression and splicing, DNA mutation/SNP detection, and gene pathway analyses ofthe mammalian metagenome (microbe and man) will be fostered by this Core as a platform for gastrointestinal and hepatic systems biology. Our mission is to provide a full service resource from experimental design to consultations about specimen processing, robust data analysis pipelines, and biostatistical support. In summary, we have created a fully integrated genomic analysis platform for investigators studying digestive diseases.

Public Health Relevance

This Core provides help with complex molecular technologies such as gene expression profiling and genomic microarray analyses, complex protein bead assays, metagenomic sequencing and microbiome analyses needed by DDC members.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK056338-12
Application #
8611914
Study Section
Special Emphasis Panel (ZDK1-GRB-8)
Project Start
Project End
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
12
Fiscal Year
2014
Total Cost
$195,625
Indirect Cost
$70,625
Name
Baylor College of Medicine
Department
Type
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Yu, Wangie; Chen, Yunyun; Dubrulle, Julien et al. (2018) Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci Rep 8:4306
Mindikoglu, Ayse L; Pappas, Stephen C (2018) Predictors of Response to Terlipressin in Hepatorenal Syndrome. Clin Gastroenterol Hepatol 16:1174
Zhou, Yong; Hancock, John F (2018) Electron microscopy combined with spatial analysis: quantitative mapping of the nano-assemblies of plasma membrane-associating proteins and lipids. Biophys Rep 4:320-328
Rajan, Anubama; Vela, Lucy; Zeng, Xi-Lei et al. (2018) Novel Segment- and Host-Specific Patterns of Enteroaggregative Escherichia coli Adherence to Human Intestinal Enteroids. MBio 9:
VanWagner, Lisa B; Kanwal, Fasiha (2018) Hepatology in a changing health care landscape: A call for health services research. Hepatology 68:1154-1162
Kennedy, Elizabeth A; King, Katherine Y; Baldridge, Megan T (2018) Mouse Microbiota Models: Comparing Germ-Free Mice and Antibiotics Treatment as Tools for Modifying Gut Bacteria. Front Physiol 9:1534
Zou, Winnie Y; El-Serag, Hashem B; Sada, Yvonne H et al. (2018) Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population. Dig Dis Sci 63:1173-1181
Cash, Brooks D (2018) Understanding and Managing IBS and CIC in the Primary Care Setting. Gastroenterol Hepatol (N Y) 14:3-15
Blutt, Sarah E (2018) The Next MacGyver: A Platform to Study Intestinal Organoids Using High-Throughput Computer-Driven Microinjection. Cell Mol Gastroenterol Hepatol 6:352-353
Collins, J; Robinson, C; Danhof, H et al. (2018) Dietary trehalose enhances virulence of epidemic Clostridium difficile. Nature 553:291-294

Showing the most recent 10 out of 1121 publications